These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8020514)

  • 1. Clinical utility and safety profile of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iomeprol: a review of its use as a contrast medium.
    Dooley M; Jarvis B
    Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iomeprol: current and future profile of a radiocontrast agent.
    Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
    Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison.
    Fattori R; Piva R; Schicchi F; Pancrazi A; Gabrielli G; Marzocchi A; Piovaccari G; Blandini A; Magnani B
    Eur J Radiol; 1994 May; 18 Suppl 1():S61-6. PubMed ID: 8020520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs.
    Valentini AL; Tartaglione T; Monti L; Marano P
    Eur J Radiol; 1994 May; 18 Suppl 1():S88-92. PubMed ID: 8020525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of safety and efficacy of iomeprol and iopamidol in carotid digital subtraction angiography.
    Beltramello A; Piovan E; Rosta L
    Eur J Radiol; 1994 May; 18 Suppl 1():S67-72. PubMed ID: 8020521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
    La Noce A; Bertani F; Lorusso V; Luzzani F; Tirone P; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S43-50. PubMed ID: 8020518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S51-60. PubMed ID: 8020519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral arteriography with a new nonionic agent: comparison of iomeprol with iopamidol.
    Ugolotti U; Larini P; Marcato C; Cusmano F; Puccianti F
    Eur J Radiol; 1994 May; 18 Suppl 1():S77-82. PubMed ID: 8020523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of iomeprol for injection in experimental animals.
    Cipolla P; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
    Morisetti A; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the radiographic efficacy of iomeprol.
    Kozuka T; Katayama H; Ebata K
    Eur J Radiol; 1994 May; 18 Suppl 1():S109-14. PubMed ID: 8020512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine viscosity after injections of iotrolan or iomeprol.
    Ueda J; Furukawa T; Higashino K; Takahashi S; Araki Y; Kubo K; Nakashima T
    Acta Radiol; 1997 Nov; 38(6):1079-82. PubMed ID: 9394674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparative study of the safety and efficacy of iomeprol in renal intra-arterial digital subtraction angiography.
    Simonetti G; Guazzaroni M; Carpanese L; Canalis GC; Urigo F
    Eur J Radiol; 1994 May; 18 Suppl 1():S73-6. PubMed ID: 8020522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.
    Gallotti A; Uggeri F; Favilla A; Cabrini M; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S1-12. PubMed ID: 8020510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New non-ionic contrast: effects on the cardiovascular system.
    Pagny JY; Gaux JC
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol.
    Heinrich M; Schneider G; Grgic A; Humke U; Kramann B; Uder M
    Invest Radiol; 2004 Jul; 39(7):406-12. PubMed ID: 15194911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
    Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan.
    Katayama H; Heneine N; van Gessel R; Taroni P; Spinazzi A
    Invest Radiol; 2001 Jan; 36(1):22-32. PubMed ID: 11176258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.